| Literature DB >> 32375989 |
Joseph J Wanford1, Jonathan C Holmes1, Christopher D Bayliss1, Luke R Green2.
Abstract
Neisseria meningitidis is a Gram-negative human commensal pathogen, with extensive phenotypic plasticity afforded by phase-variable (PV) gene expression. Phase variation is a stochastic switch in gene expression from an ON to an OFF state, mediated by localized hypermutation of simple sequence repeats (SSRs). Circulating N. meningitidis clones vary in propensity to cause disease, with some clonal complexes (ccs) classified as hypervirulent and others as carriage-associated. We examined the PV gene repertoires, or phasome, of these lineages in order to determine whether phase variation contributes to disease propensity. We analysed 3328 genomes representative of nine circulating meningococcal ccs with PhasomeIt, a tool that identifies PV genes by the presence of SSRs and homologous gene clusters. The presence, absence and functions of all identified PV gene clusters were confirmed by annotation or blast searches within the Neisseria PubMLST database. While no significant differences were detected in the number of PV genes or the core, conserved phasome content between hypervirulent and carriage lineages, individual ccs exhibited major variations in PV gene numbers. Phylogenetic clusters produced by phasome or core genome analyses were similar, indicating co-evolution of PV genes with the core genome. While conservation of PV clusters is high, with 76 % present in all meningococcal isolates, maintenance of an SSR is variable, ranging from conserved in all isolates to present only in a single cc, indicating differing evolutionary trajectories for each lineage. Diverse functional groups of PV genes were present across the meningococcal lineages; however, the majority directly or indirectly influence bacterial surface antigens and could impact on future vaccine development. Finally, we observe that meningococci have open pan phasomes, indicating ongoing evolution of PV gene content and a significant potential for adaptive changes in this clinically relevant genus.Entities:
Keywords: Neisseria; carriage; clonal complex; hypervirulence; microevolution; phase variation
Mesh:
Substances:
Year: 2020 PMID: 32375989 PMCID: PMC7371114 DOI: 10.1099/mgen.0.000367
Source DB: PubMed Journal: Microb Genom ISSN: 2057-5858
Fig. 1.Clustering of PV genes in meningococcal ccs. (a) Box plot depicting the range, median, and first and third quartiles of the number of PV genes detected for each cc. Statistical significance was analysed by two-way ANOVA. ****, P <0.0005. The mean number of PV genes across all ccs is depicted with a dotted line. C/E, Carriage/endemic; HV, hypervirulent. (b) Neighbour-joining tree based on the presence or absence of PV homology groups across all ccs. Colours corresponding to each cc are shown in the key.
Fig. 2.Presence of PV genes across each cc. Core-phasome data were used to derive the per cent presence of PV genes above a 50 % threshold for all isolates. Where genes were core in one cc, but not in another, the respective loci were queried against the ‘non-core’ cc dataset to provide the per cent conservation below the 50 % core-phasome cut-off. Genes are sorted from top to bottom, on the highest mean conservation of phase variation across all ccs. The colour gradient represents the percentage of isolates with a PV copy of the respective gene ranging from blue (low conservation) to yellow (high conservation). To give an overview of population structure, an MLST tree was included based on the PubMLST typing scheme for meningococcus using one representative isolate from each cc. The MLST tree was drawn using iTOL software, through the PubMLST interface where the scale bar denotes single nucleotide polymorphisms.
Fig. 3.Presence of modular PV genes and their cognate SSRs in hypervirulent and carriage-associated meningococci. The heatmap demonstrates whether genes were in the core phasome. Bars are depicted as follows: core – present in greater than 50 % of isolates and phase variation in greater than 50 % of isolates (green); no gene – absent from the core because of lack of the loci in 50 % of isolates (red); or no SSR – presence of the gene but lacked an SSR in 50 % of the isolates (yellow). Strains are grouped based on their predicted virulence (hypervirulent vs carriage), genes are arranged into modules by their known or predicted function. LOS, Lipo-oligosaccharide; MC, multi-copy; OMP, outer-membrane protein; RM, restriction modification; SC, single-copy.
Functional analysis of core and accessory PV genes of meningococcus
Functions of genes were either discerned from published literature where available or from predicted functional domains using a blastp search. Predominant SSRs are those that make up more than 50 % of the loci across the dataset. Evidence for phase variation was split into the following: known, functional studies in the literature; alignment, SSR present and differential tract length observed at homologous loci; and SSR present, SSR identified in the ORF but no alignment-based evidence for phase variation.
|
NEIS number (gene) |
Function/functional domain |
Predominant SSR |
ccs gene conserved and subject to phase variation |
Evidence for variation |
|---|---|---|---|---|
|
| ||||
|
NEIS0001 ( |
UDP-3- |
GC |
32, 213, 22, 23, 162, 461, new ST |
SSR present |
|
NEIS2011 ( |
LOS glucosyltransferase |
C |
11, 32, 22, 23, 162 |
Known [ |
|
NEIS2152 ( |
Addition of Kdo moiety to lipid A |
G |
32, 213, 23, 461 |
SSR present |
|
NEIS1902 ( |
|
C |
11, 269 |
Known [ |
|
NEIS1816 ( |
Rabinose-5-phosphate isomerase |
GC |
22, new ST |
SSR present |
|
NEIS2154 ( |
Galactosyltransferase |
G |
41/44 |
Known [ |
|
| ||||
|
NEIS0568 ( |
Glycosylation of pilus |
CAACAAA |
All |
Known [ |
|
NEIS0033 ( |
Retraction of pilus |
C |
All |
Known [ |
|
NEIS0213 ( |
Glycosylation of pilus |
G |
32, 269, 41/44, 22, 162, 461, new ST |
Known [ |
|
NEIS0380 ( |
Glycosylation of pilus |
G |
269, 41/44, 22, 162, new ST |
Known [ |
|
NEIS0401 ( |
Glycosylation of pilus |
C |
41/44, 22, 23, 162 |
Known [ |
|
|
Silent loci which recombines with |
GCCGAC |
32, 213, 23, 461 |
SSR present |
|
| ||||
|
NEIS1310 ( |
Methylation and foreign DNA restriction |
GCCA |
11, 32, 213, 269, 41/44, 162, 461, new ST |
Known [ |
|
NEIS1194 ( |
Methylation and foreign DNA restriction |
CCCAA |
41/44, 22 |
Known [ |
|
NEIS2364 ( |
Methylation and foreign DNA restriction |
ACCGA |
41/44, 22 |
Known [ |
|
| ||||
|
NEIS1943 ( |
Autotransporter |
C |
11, 32, 213, 41/44, 22, 23, 162, new ST |
Known [ |
|
NEIS1859 ( |
Contains autotransporter domain (UniProt) |
GCAA |
32, 213, 269, 41/44, 22, 23, 162, 461, new ST |
SSR present |
|
NEIS1783 |
Outer membrane protein class 4 |
GAACCC |
32, 213, 269, 23, 162, 461, new ST |
SSR present |
|
NEIS1974 ( |
Autotransporter |
C |
11, 32, 213, 269, 41/44, 162, 461, new ST |
Known [ |
|
NEIS1634 |
Membrane fusion protein/efflux pump |
GC |
32, 213, 22, 23, 162, 461, new ST |
SSR present |
|
NEIS0774 ( |
ATP-dependent Clp protease |
TGAAGA |
11, 32, 213, 162, 461 |
SSR present |
|
NEIS0978 |
Adhesin |
C |
11, 32, 213, 269 |
SSR present |
|
NEIS1364 ( |
Porin |
G |
All |
Known [ |
|
NEIS1969 ( |
Adhesin/invasin |
TAAA |
11, 32, 213 |
Known [ |
|
| ||||
|
hmbR ( |
Haemoglobin receptor |
G |
11, 32, 213, 269, 41/44, 162, 461, new ST |
Known [ |
|
NEIS1963 ( |
Ferric enterobactin transporter |
C |
32, 269, 41/44, 23 |
Known [ |
|
NEIS1946 ( |
Haemoglobin receptor |
G |
11, 22, 23 |
Known [ |
|
NEIS1691 ( |
Transferrin-binding protein |
ATAACAAA |
22, 23 |
SSR present |
|
NEIS1469 ( |
Lactoferrin receptor |
AAGCTG |
11, 23 |
SSR present |
|
NEIS1587 ( |
Haem utilization protein (haem oxygenase) |
GAAGCC |
11, 461 |
SSR present |
|
| ||||
|
NEIS0354 ( |
Glutamate-1-semialdehyde aminotransferase |
CGGTTG |
All |
SSR present |
|
NEIS0276 |
Peptidyl-prolyl cis-trans isomerase |
GCCAAAGCT |
All |
SSR present |
|
NEIS0186 ( |
4-Hydroxythreonine-4-phosphate dehydrogenase |
GC |
32, 213, 269, 22, 23, 162, 461, new ST |
SSR present |
|
NEIS0200 |
Ferredoxin |
GC |
213, 22, new ST |
SSR present |
|
NEIS1778 ( |
Aldose 1-epimerase; carbohydrate metabolism |
CCGCTACCC |
22 |
SSR present |
|
NEIS0501 |
Serine acetyltransferase |
CCGCGG |
461 |
SSR present |
|
NEIS1749 |
UDP-MurNAc-pentapeptide synthetase |
CGC |
162 |
SSR present |
|
NEIS0403 ( |
Riboflavin biosynthesis protein RibD |
CGG |
269 |
SSR present |
|
| ||||
|
NEIS1518 ( |
Alanyl-tRNA synthetase |
ACGCGC |
11, 32, 213, 269, 22, 23, 162, 461, new ST |
SSR present |
|
NEIS1436 ( |
Arginyl-tRNA synthetase |
ACGCGC |
32, 213, 269, 41/44, 22, 23, 461, new ST |
SSR present |
|
NEIS2017 ( |
tRNA pseudouridine synthase A |
C |
11, 32, 213, 23, 162 |
SSR present |
|
NEIS0183 |
Ribonuclease HII |
T |
11, 22, 461, new ST |
SSR present |
|
NEIS1106 |
Transcriptional regulator |
TG |
162 |
SSR present |
|
| ||||
|
NEIS2000 |
|
CG |
32, 213, 22, 23, 162, 461, new ST |
SSR present |
|
NEIS0405 |
|
GCCAAAGCT |
32, 269, 22, 23, 162, new ST |
SSR present |
|
NEIS3112 |
|
CAAG |
41/44, 162 |
SSR present |
|
NEIS2475 |
|
CCTT |
41/44, 461, new ST |
SSR present |
|
NEIS2556 |
|
AT |
22, 23, 162 |
SSR present |
|
NEIS0513 |
|
G |
269 |
SSR present |
|
NEIS0782 |
|
ACGGAT |
213, 162 |
SSR present |
|
NEIS2022 |
|
CCTGTTT |
269 |
SSR present |
|
NEIS3062 |
|
ATTATC |
162 |
SSR present |
|
NEIS1801 |
|
A |
32 |
SSR present |
|
NEIS0317 |
|
GACACG |
162 |
SSR present |
|
NEIS1357 |
|
C |
162 |
SSR present |
|
| ||||
|
|
Adhesion to epithelial cells |
CTTCT |
|
Known [ |
|
| ||||
|
NEIS1156 |
Homology to |
G |
All |
SSR present |
|
NEIS2930 ( |
Autotransporter precursor |
AGCA |
11, 32, 41/44, 22, 461, new ST |
SSR present |
|
NEIS2780 |
Type-1 restriction enzyme specificity MPN_089 |
G |
41/44 |
SSR present |
|
| ||||
|
NEIS0950 |
Replication initiation |
G |
213 |
SSR present |
|
NEIS0009 |
Uncharacterized membrane protein |
A |
All |
SSR present |
|
NEIS1297 |
Uncharacterized membrane protein |
TAGGCT |
11, 213, 41/44, 22, 23, 162, 461 |
SSR present |
|
NEIS0092 |
Uncharacterized membrane protein |
G |
11, 22, 461, new ST |
SSR present |
Fig. 4.Core- and accessory-phasome sizes of meningococcal ccs. (a) The size of core phasome was derived for each cc, by setting a cut-off of being present and PV in greater than 50, 80 or 95 % of isolates. Statistical significance was determined by t-test, ns denotes no significance. (b) Accessory-phasome sizes of each cc derived from a random sample of 50 genomes from each cc. Statistical significance was determined using a t-test. (c) Correlation between total number of genome sequences analysed for each cc and the size of the accessory phasome. Statistical significance was determined using Pearson‘s correlation. (d) Pan-phasome analysis of the number of PV genes detected with an incremental number of genomes analysed for each cc. The inset shows the range where genomes were still being added for all ccs. Data points in (a), (b) and (d) corresponding to different ccs are colour coded as displayed in the key.